Skip to content
Screener

MBX Biosciences, Inc. MBX Return on invested capital

Return on invested capital at other companies

Eli Lilly logo
Eli LillyLLY
39.7%+10.3pp
Amgen logo
AmgenAMGN
14.8%+3.6pp
Viking Therapeutics logo
Viking TherapeuticsVKTX
-59.2%-292pp
Amylyx Pharmaceuticals, Inc. logo
Amylyx Pharmaceuticals, Inc.AMLX
-104.3%-16.8pp
Nurix Therapeutics, Inc. logo
Nurix Therapeutics, Inc.NRIX
-89.5%+48.4pp
Xenon Pharmaceuticals logo
Xenon PharmaceuticalsXENE
-54%+2.2pp

Other financials

Income statement

See full
Operating income-$27.3M-2.8%
Net income-$23.5M+1.5%
EPS (diluted)-$0.50+29.6%

Balance sheet

See full
Cash & equivalents$45.2M+51.2%
Total debt$555.0K+327%
Total equity$437.8M+85.9%
Total assets$452.7M+84.1%

Cash flow

See full
Operating cash flow-$20.2M+10.9%
CapEx$437.0K+1,357%
Free cash flow-$20.6M+9.1%

Valuation

See full
Market cap$3.19B+719%
Enterprise value$3.15B+798%

Returns & leverage

See full
Return on equity-25.7%
Debt / equity0.0×
Current ratio30.8×+7.5×

Where this comes from

Calculated from MBX Biosciences, Inc.’s reported figures.

Based on trailing twelve months.

The source filing: MBX Biosciences, Inc.’s 10-Q, filed May 7, 2026. Open the filing →

Filed
May 7, 2026, 9:03 AM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001193125-26-210593

FAQ

What is MBX Biosciences, Inc.'s return on invested capital?
MBX Biosciences, Inc. (MBX) reported return on invested capital of -33% in Q1 2026.
What does return on invested capital mean?
Net operating profit after tax (operating income taxed at the effective rate) divided by average invested capital (debt plus equity minus cash). Measures the after-tax return on all capital put to work in the business, independent of capital structure.

Ask your AI about MBX Biosciences, Inc.'s return on invested capital.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude